Hypofractionated radiotherapy regimens after organ-sparing surgery for stages I–IIa breast cancer

Abstract

The results of basic clinical randomized trials of hypofractionated (HF) radiotherapy (R T) regimens used after organ-sparing su rgery for Stages I-IIa breast cancer (BC) were analyzed. The HF adjuvant RT regimens were shown to be safe and an alternative to the standard RT in patients with BC after organ-saving operations.

Keywords

• breast cancer
• radiotherapy
• hypofractionated regimen